Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity

作者: Dilys M. Parry , Roswell Eldridge , Muriel I. Kaiser-Kupfer , Evrydiki A. Bouzas , Anita Pikus

DOI: 10.1002/AJMG.1320520411

关键词: AudiometryFundus (eye)Age of onsetDermatologyNeurofibromatosisMagnetic resonance imagingMedicineAsymptomaticCataractsNeurofibromatosis type 2

摘要: To determine the spectrum of manifestations in neurofibromatosis 2 (NF2) and to assess possible heterogeneity, we evaluated 63 affected individuals from 32 families. Work-up included skin neurologic examinations, audiometry, a complete ophthalmology examination with slit-lamp biomicroscopy lens fundus, gadolinium-enhanced MRI brain and, some, spine. Mean age-at-onset 58 was 20.3 years; initial symptoms resulted vestibular schwannomas (44.4%), other CNS tumors (22.2%), (12.7%), ocular including cataracts retinal hamartomas (12.7%). Five asymptomatic were diagnosed through screening. Vestibular documented 62 (98.4%); findings (81.0%), (67.7%), spinal (67.4%), meningiomas (49.2%). Usually, clinical course similar within families but differed among assigned three proposed subtypes (representing mild, intermediate, severe NF2) based on age-at-onset, presence or absence than schwannomas, hamartomas. Comparisons for many parameters demonstrated that patients mild subtype those two most parameters, none distinguished intermediate subtype. Thus, there are likely rather NF2. Classification may aid counseling about long-term prognosis formulating individualized guidelines medical surveillance.

参考文章(44)
Marina Frontali, James F. Gusella, Steven A. Narod, Robert L. Martuza, Martin Ruttledge, Dilys M. Parry, Guy A. Rouleau, Roswell Eldridge, Jillian Parboosingh, Gilbert M. Lenoir, Jonathan Haines, Georges Fischer, Neurofibromatosis type 2 appears to be a genetically homogeneous disease American Journal of Human Genetics. ,vol. 51, pp. 486- 496 ,(1992)
Bernd R. Seizinger, Robert L. Martuza, James F. Gusella, Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature. ,vol. 322, pp. 644- 647 ,(1986) , 10.1038/322644A0
K Landau, G M Yasargil, Ocular fundus in neurofibromatosis type 2. British Journal of Ophthalmology. ,vol. 77, pp. 646- 649 ,(1993) , 10.1136/BJO.77.10.646
W V Good, M C Erodsky, M S Edwards, W F Hoyt, Bilateral retinal hamartomas in neurofibromatosis type 2 British Journal of Ophthalmology. ,vol. 75, pp. 190- 190 ,(1991) , 10.1136/BJO.75.3.190
J. D. Sidman, V. N. Carrasco, R. A. Whaley, H. C. Pillsbury, Gadolinium: The New Gold Standard for Diagnosing Cerebellopontine Angle Tumors Archives of Otolaryngology-head & Neck Surgery. ,vol. 115, pp. 1244- 1247 ,(1989) , 10.1001/ARCHOTOL.1989.01860340098026
E A Bouzas, V Freidlin, D M Parry, R Eldridge, M I Kaiser-Kupfer, Lens opacities in neurofibromatosis 2: further significant correlations. British Journal of Ophthalmology. ,vol. 77, pp. 354- 357 ,(1993) , 10.1136/BJO.77.6.354
Mieko Okamoto, Masayuki Sasaki, Kenji Sugio, Chieko Sato, Takeo Iwama, Tatsuro Ikeuchi, Akira Tonomura, Takehiko Sasazuki, Michiko Miyaki, Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature. ,vol. 331, pp. 273- 277 ,(1988) , 10.1038/331273A0
Vincent M. Riccardi, Von Recklinghausen neurofibromatosis. The New England Journal of Medicine. ,vol. 305, pp. 1617- 1627 ,(1981) , 10.1056/NEJM198112313052704
E. Cotlier, Café-au-lait spots of the fundus in neurofibromatosis. Archives of Ophthalmology. ,vol. 95, pp. 1990- 1992 ,(1977) , 10.1001/ARCHOPHT.1977.04450110084007